Compare MCRB & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | MDV |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 157.4M |
| IPO Year | 2015 | 2022 |
| Metric | MCRB | MDV |
|---|---|---|
| Price | $15.04 | $15.04 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 43.7K | 36.0K |
| Earning Date | 03-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 7.83% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | $351,000.00 | ★ $47,479,000.00 |
| Revenue This Year | N/A | $0.13 |
| Revenue Next Year | N/A | $0.71 |
| P/E Ratio | $24.47 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.53 | $13.62 |
| 52 Week High | $29.98 | $17.15 |
| Indicator | MCRB | MDV |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 56.05 |
| Support Level | $14.41 | $14.93 |
| Resistance Level | $16.12 | $15.51 |
| Average True Range (ATR) | 0.83 | 0.34 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 44.28 | 65.22 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.